These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

574 related articles for article (PubMed ID: 30786997)

  • 21. The Collaborative Randomised Amnioinfusion for Meconium Project (CRAMP): 2. Zimbabwe.
    Mahomed K; Mulambo T; Woelk G; Hofmeyr GJ; Gülmezoğlu AM
    Br J Obstet Gynaecol; 1998 Mar; 105(3):309-13. PubMed ID: 9532992
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immediate delivery versus expectant monitoring for hypertensive disorders of pregnancy between 34 and 37 weeks of gestation (HYPITAT-II): an open-label, randomised controlled trial.
    Broekhuijsen K; van Baaren GJ; van Pampus MG; Ganzevoort W; Sikkema JM; Woiski MD; Oudijk MA; Bloemenkamp KW; Scheepers HC; Bremer HA; Rijnders RJ; van Loon AJ; Perquin DA; Sporken JM; Papatsonis DN; van Huizen ME; Vredevoogd CB; Brons JT; Kaplan M; van Kaam AH; Groen H; Porath MM; van den Berg PP; Mol BW; Franssen MT; Langenveld J;
    Lancet; 2015 Jun; 385(9986):2492-501. PubMed ID: 25817374
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcomes of Term Induction in Trial of Labor After Cesarean Delivery: Analysis of a Modern Obstetric Cohort.
    Lappen JR; Hackney DN; Bailit JL
    Obstet Gynecol; 2015 Jul; 126(1):115-23. PubMed ID: 26241264
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Planned delivery or expectant management for late preterm pre-eclampsia in low-income and middle-income countries (CRADLE-4): a multicentre, open-label, randomised controlled trial.
    Beardmore-Gray A; Vousden N; Seed PT; Vwalika B; Chinkoyo S; Sichone V; Kawimbe AB; Charantimath U; Katageri G; Bellad MB; Lokare L; Donimath K; Bidri S; Goudar S; Sandall J; Chappell LC; Shennan AH;
    Lancet; 2023 Jul; 402(10399):386-396. PubMed ID: 37393919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Home telemonitoring versus hospital care in complicated pregnancies in the Netherlands: a randomised, controlled non-inferiority trial (HoTeL).
    Bekker MN; Koster MPH; Keusters WR; Ganzevoort W; de Haan-Jebbink JM; Deurloo KL; Seeber L; van der Ham DP; Zuithoff NPA; Frederix GWJ; van den Heuvel JFM; Franx A
    Lancet Digit Health; 2023 Mar; 5(3):e116-e124. PubMed ID: 36828605
    [TBL] [Abstract][Full Text] [Related]  

  • 26. "GINEXMAL RCT: Induction of labour versus expectant management in gestational diabetes pregnancies".
    Maso G; Alberico S; Wiesenfeld U; Ronfani L; Erenbourg A; Hadar E; Yogev Y; Hod M;
    BMC Pregnancy Childbirth; 2011 Apr; 11():31. PubMed ID: 21507262
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Which intrauterine growth restricted fetuses at term benefit from early labour induction? A secondary analysis of the DIGITAT randomised trial.
    Tajik P; van Wyk L; Boers KE; le Cessie S; Zafarmand MH; Roumen F; van der Post JA; Porath M; van Pampus MG; Spaanderdam ME; Kwee A; Duvekot JJ; Bremer HA; Delemarre FM; Bloemenkamp KW; de Groot CJ; Willekes C; van Lith JM; Bossuyt PM; Mol BW; Scherjon SA;
    Eur J Obstet Gynecol Reprod Biol; 2014 Jan; 172():20-5. PubMed ID: 24192662
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Perinatal mortality associated with induction of labour versus expectant management in nulliparous women aged 35 years or over: An English national cohort study.
    Knight HE; Cromwell DA; Gurol-Urganci I; Harron K; van der Meulen JH; Smith GCS
    PLoS Med; 2017 Nov; 14(11):e1002425. PubMed ID: 29136007
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elective caesarean section at 38 weeks versus 39 weeks: neonatal and maternal outcomes in a randomised controlled trial.
    Glavind J; Kindberg SF; Uldbjerg N; Khalil M; Møller AM; Mortensen BB; Rasmussen OB; Christensen JT; Jørgensen JS; Henriksen TB
    BJOG; 2013 Aug; 120(9):1123-32. PubMed ID: 23682628
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of labor before 40 weeks is associated with lower rate of cesarean delivery in women with gestational diabetes mellitus.
    Melamed N; Ray JG; Geary M; Bedard D; Yang C; Sprague A; Murray-Davis B; Barrett J; Berger H
    Am J Obstet Gynecol; 2016 Mar; 214(3):364.e1-8. PubMed ID: 26928149
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Maternal and perinatal outcomes after elective induction of labor at 39 weeks in uncomplicated singleton pregnancy: a meta-analysis.
    Sotiriadis A; Petousis S; Thilaganathan B; Figueras F; Martins WP; Odibo AO; Dinas K; Hyett J
    Ultrasound Obstet Gynecol; 2019 Jan; 53(1):26-35. PubMed ID: 30298532
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does induction of labor at 41 weeks (early, mid or late) improve birth outcomes in low-risk pregnancy? A nationwide propensity score-matched study.
    Ravelli ACJ; van der Post JAM; de Groot CJM; Abu-Hanna A; Eskes M
    Acta Obstet Gynecol Scand; 2023 May; 102(5):612-625. PubMed ID: 36915238
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Labor induction versus expectant management at early term in pregnancies with second trimester elevated human chorionic gonadotropin or alpha fetoprotein.
    Yefet E; Kuzmin O; Schwartz N; Basson F; Nachum Z
    J Obstet Gynaecol Res; 2018 Jun; 44(6):1049-1056. PubMed ID: 29516643
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nonmedically indicated induction in morbidly obese women is not associated with an increased risk of cesarean delivery.
    Kawakita T; Iqbal SN; Huang CC; Reddy UM
    Am J Obstet Gynecol; 2017 Oct; 217(4):451.e1-451.e8. PubMed ID: 28578171
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Labor induction versus expectant management for postterm pregnancies: a systematic review with meta-analysis.
    Sanchez-Ramos L; Olivier F; Delke I; Kaunitz AM
    Obstet Gynecol; 2003 Jun; 101(6):1312-8. PubMed ID: 12798542
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Labor induction at 41
    Place K; Rahkonen L; Tekay A; Väyrynen K; Orden MR; Vääräsmäki M; Uotila J; Tihtonen K; Rinne K; Mäkikallio K; Heinonen S; Kruit H
    Acta Obstet Gynecol Scand; 2024 Mar; 103(3):505-511. PubMed ID: 38112629
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk of adverse pregnancy outcomes of late- and postterm pregnancies in advanced maternal age: A national cohort study.
    Kortekaas JC; Kazemier BM; Keulen JKJ; Bruinsma A; Mol BW; Vandenbussche F; Van Dillen J; De Miranda E
    Acta Obstet Gynecol Scand; 2020 Aug; 99(8):1022-1030. PubMed ID: 32072610
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intrapartum and neonatal mortality in primary midwife-led and secondary obstetrician-led care in the Amsterdam region of the Netherlands: A retrospective cohort study.
    Wiegerinck MM; van der Goes BY; Ravelli AC; van der Post JA; Klinkert J; Brandenbarg J; Buist FC; Wouters MG; Tamminga P; de Jonge A; Mol BW
    Midwifery; 2015 Dec; 31(12):1168-76. PubMed ID: 26386517
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks' gestation (HYPITAT): a multicentre, open-label randomised controlled trial.
    Koopmans CM; Bijlenga D; Groen H; Vijgen SM; Aarnoudse JG; Bekedam DJ; van den Berg PP; de Boer K; Burggraaff JM; Bloemenkamp KW; Drogtrop AP; Franx A; de Groot CJ; Huisjes AJ; Kwee A; van Loon AJ; Lub A; Papatsonis DN; van der Post JA; Roumen FJ; Scheepers HC; Willekes C; Mol BW; van Pampus MG;
    Lancet; 2009 Sep; 374(9694):979-988. PubMed ID: 19656558
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of labour at 41 weeks of gestation versus expectant management and induction of labour at 42 weeks of gestation: A cost-effectiveness analysis.
    Alkmark M; Wennerholm UB; Saltvedt S; Bergh C; Carlsson Y; Elden H; Fadl H; Jonsson M; Ladfors L; Sengpiel V; Wesström J; Hagberg H; Svensson M
    BJOG; 2022 Dec; 129(13):2157-2165. PubMed ID: 34534404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.